Internal medicine-epitomes of progress: cimetidine in the treatment of peptic ulcer disease

J P Cello. West J Med. 1978 Jul.

. 1978 Jul;129(1):51.

No abstract available

Similar articles

Cimetidine and perforated peptic ulcer.
McKay AJ, McArdle CS. McKay AJ, et al. Br J Surg. 1982 Jun;69(6):319-20. doi: 10.1002/bjs.1800690609. Br J Surg. 1982. PMID: 7082957
Effects of cimetidine on the pharmacokinetics of proguanil in healthy subjects and in peptic ulcer patients.
Kolawole JA, Mustapha A, Abdul-Aguye I, Ochekpe N, Taylor RB. Kolawole JA, et al. J Pharm Biomed Anal. 1999 Sep;20(5):737-43. doi: 10.1016/s0731-7085(99)00058-8. J Pharm Biomed Anal. 1999. PMID: 10701981 Clinical Trial.
Trends in peptic ulcer related diseases from 1972 to 1980. Hospital activity analysis data and general practice cimetidine prescribing levels.
O'Connor PC, Griffiths K, Shanks RG. O'Connor PC, et al. Eur J Clin Pharmacol. 1983;24(4):435-40. doi: 10.1007/BF00609882. Eur J Clin Pharmacol. 1983. PMID: 6861858
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1978 Feb;15(2):93-131. doi: 10.2165/00003495-197815020-00002. Drugs. 1978. PMID: 342231 Review.
The impact of cimetidine on the treatment of acid-peptic disease.
Fleshler B. Fleshler B. Prim Care. 1981 Jun;8(2):195-203. Prim Care. 1981. PMID: 7027288 Review. No abstract available.